79 related articles for article (PubMed ID: 2274625)
1. Characteristics of placebo response during long-term treatment of panic disorder.
Dager SR; Khan A; Cowley D; Avery DH; Elder J; Roy-Byrne P; Dunner DL
Psychopharmacol Bull; 1990; 26(3):273-8. PubMed ID: 2274625
[TBL] [Abstract][Full Text] [Related]
2. Development of a patient-reported assessment to identify placebo responders in a generalized anxiety disorder trial.
Feltner D; Hill C; Lenderking W; Williams V; Morlock R
J Psychiatr Res; 2009 Oct; 43(15):1224-30. PubMed ID: 19423131
[TBL] [Abstract][Full Text] [Related]
3. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
[TBL] [Abstract][Full Text] [Related]
4. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
Dunner DL; Ishiki D; Avery DH; Wilson LG; Hyde TS
J Clin Psychiatry; 1986 Sep; 47(9):458-60. PubMed ID: 2875064
[TBL] [Abstract][Full Text] [Related]
5. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
Alpert JE; Franznick DA; Hollander SB; Fava M
J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
[TBL] [Abstract][Full Text] [Related]
6. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
Lydiard RB; Ballenger JC; Rickels K
J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
[TBL] [Abstract][Full Text] [Related]
7. Clonazepam versus alprazolam in the treatment of panic disorder: interim analysis of data from a prospective, double-blind, placebo-controlled trial.
Tesar GE; Rosenbaum JF; Pollack MH; Herman JB; Sachs GS; Mahoney EM; Cohen LS; McNamara M; Goldstein S
J Clin Psychiatry; 1987 Oct; 48 Suppl():16-21. PubMed ID: 3312179
[TBL] [Abstract][Full Text] [Related]
8. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, placebo-controlled comparison of clonazepam and alprazolam for panic disorder.
Tesar GE; Rosenbaum JF; Pollack MH; Otto MW; Sachs GS; Herman JB; Cohen LS; Spier SA
J Clin Psychiatry; 1991 Feb; 52(2):69-76. PubMed ID: 1993639
[TBL] [Abstract][Full Text] [Related]
10. Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
Deltito JA; Argyle N; Klerman GL
J Clin Psychiatry; 1991 Mar; 52(3):121-7. PubMed ID: 2005075
[TBL] [Abstract][Full Text] [Related]
11. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
[TBL] [Abstract][Full Text] [Related]
12. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
Pyke RE; Greenberg HS
J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
[TBL] [Abstract][Full Text] [Related]
13. Alprazolam in the treatment of neurotic anxiety.
Kerry RJ; McDermott CM
Pharmatherapeutica; 1983; 3(7):451-5. PubMed ID: 6142462
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
15. Alprazolam in the treatment of panic disorders.
Liebowitz MR; Fyer AJ; Gorman JM; Campeas R; Levin A; Davies SR; Goetz D; Klein DF
J Clin Psychopharmacol; 1986 Feb; 6(1):13-20. PubMed ID: 2869059
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome after acute treatment with alprazolam or clonazepam for panic disorder.
Pollack MH; Otto MW; Tesar GE; Cohen LS; Meltzer-Brody S; Rosenbaum JF
J Clin Psychopharmacol; 1993 Aug; 13(4):257-63. PubMed ID: 8376613
[TBL] [Abstract][Full Text] [Related]
17. Alprazolam, propranolol, and placebo in the treatment of panic disorder and agoraphobia with panic attacks.
Munjack DJ; Crocker B; Cabe D; Brown R; Usigli R; Zulueta A; McManus M; McDowell D; Palmer R; Leonard M
J Clin Psychopharmacol; 1989 Feb; 9(1):22-7. PubMed ID: 2651490
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.
Rynn M; Russell J; Erickson J; Detke MJ; Ball S; Dinkel J; Rickels K; Raskin J
Depress Anxiety; 2008; 25(3):182-9. PubMed ID: 17311303
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy of propranolol, chlordiazepoxide, and placebo in the treatment of anxiety: a double-blind trial.
Meibach RC; Dunner D; Wilson LG; Ishiki D; Dager SR
J Clin Psychiatry; 1987 Sep; 48(9):355-8. PubMed ID: 3305488
[TBL] [Abstract][Full Text] [Related]
20. Alprazolam in the treatment of panic attack patients with and without major depression.
Pyke RE; Kraus M
J Clin Psychiatry; 1988 Feb; 49(2):66-8. PubMed ID: 3338978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
